Zambia Launches Long-Acting HIV Prevention Drug By Honester Mshoka Zambia has launched the new long-acting pre-exposure prophylaxis -PrEP, Lenacapavir, bringing renewed hope to young people and other vulnerable populations. The Pre-Exposure Prophylaxis option provides six months of protection with a single dose for individuals who are HIV-negative. Health Minister ELIJAH MUCHIMA says the introduction of Lenacapavir marks Zambia’s leadership in the global AIDS response and shows the country’s abi

11 reactions | Preexposure prophylaxis (PrEP) is an antiviral medication effective for HIV prevention. In a new JAMA Insights article, Matthew A. Spinelli, Kenneth Ngure, and Monica Gandhi discuss the common forms of PrEP, who would most benefit from PrEP, and what clinicians should know before prescribing. https://ja.ma/3Youyjy | JAMA | Facebook